Our Purpose - Libero Pharma

Providing patients with a new way to benefit from naltrexone

Libero’s purpose is to bring a new wave of transdermal treatments for numerous chronic conditions that have been shown to benefit from opioid receptor antagonism

Enabling stable, sustained plasma levels, drug delivery via a transdermal patch is an ideal treatment modality for many chronic conditions

The scale of unmet need and potential of Libero’s lead medicine led to the National Institute of Drug Abuse (NIDA) in the US awarding Libero a 5 year development grant to bring it to market

Benefits of transdermal vs daily oral delivery

In the case of oral naltrexone, spikes in plasma concentration of the primary metabolite β-Naltrexol are also seen, increasing the risk of adverse effects. This is not expected with transdermal use.

Transdermal delivery

Patient-friendly, sustained drug delivery

Unmet need

Targeting conditions with a large and growing unmet need

Expedited regulatory pathway

Leveraging established data on the compounds to reduce time needed to be clinic-ready

Patent-protection

Patented formulations specific to different indications

Transdermal delivery

Unmet need

Expedited regulatory pathway

Patent-protection

Enquire now